| 摘要(英) |
In the trends of the aging population in advanced countries and the increasing of the gross national income in the underdevelopment countries, the demand scale and the importance of the medical device industry are increasingly concerned. As the medical equipment industry and people’’s health are closely related, it is a essential industry to help humans in disease prevention, diagnosis, mitigation and treatment, therefore it is less significant fluctuations in demand due to the changes on the economy. In terms of knowledge and technology, Taiwan’’s medical device industry is catching up with many developed countries. As the medical device industry in compliance with economic and social’s benefits, and our country has the technical capacity and infrastructure in developing medical device industry, over the years, our government to promote the industry for our country’’s future development of key industries. This paper in addition to discussing the industry overview and the future development direction of this medical device industry, this paper also analyzed the key factors which to impact Taiwan’’s medical device industry in business performance.
Empirical results of this study found that in the impacts of the performance indicators’ for return on equity or earnings per share in Taiwan’’s medical device industry are roughly the same. For three items of market share, chronic disease death rates and the export changed value are all statistically significant level of positive. It shows the market share can affect firms’’ pricing power and thus improve the vendor performance; and chronic disease death rates will affect the government’’s investment in the health care needs, and indirectly affect the profitability of medical device manufacturers; to enhance the export changed value, but also the key point to develop the medical device industry needs to focus on. And the asset sales ratio and fixed asset ratio for return on equity, also reached statistical significance level of negative, it indicates the inefficient use of assets and other issues in medical device manufacturers. The financial crisis variables in the model evaluation results, for the return on equity and earnings per share are presented insignificant relationship. It may be due to Taiwan’’s medical device industry is in a new development stage, and as inexpensive Taiwanese manufacturers of medical device, in the financial crisis factor will lead to a part of an international brand manufacturers turned to cooperate with Taiwan manufacturers, so the impact is small for the medical device .
|
| 參考文獻 |
一、中文文獻：
﹝1﹞ 王友慶，「金融產業結構行為與績效之研究--以台灣金融控股公司為例」，長榮大學經營管理研究所，2005。
﹝2﹞ 江佩珊，「台灣地區人壽保險業市場結構、行為與績效之研究」，朝陽科技大學財務經融系碩士班，2001
﹝3﹞ 李顯章，「台灣地區醫療儀器業發展關鍵成功因素之探討」，國立中興大學企業管理學系，1998。
﹝4﹞ 邱永和、胡均立與曹嘉麟，「台灣生物科技廠商之成本效率分析」，農業與經濟，31 卷 : 55-78，2003。
﹝5﹞ 林飛雄，「醫療器材業經營及融資規劃之研究-以聯合骨科器材公司為例」，國立政治大學經營管理學程，2003。
﹝6﹞ 周雅雲，「影響我國生物科技廠商財務績效之因素」，東吳大學經濟學系，2005。
﹝7﹞ 吳娟娟，「財務績效指標之重要性分析研究─以台灣化學工業上市公司為例」，中原大學會計研究所，2002。
﹝8﹞ 洪仁財、沈永祺、林亭汝，「台灣TFT-LCD產業結構、廠商行為與經營績效」，國立交通大學管理學院碩士在職專班，2009。
﹝9﹞ 財信出版社，「台灣生技醫療產業新焦點」，2010年10月。
﹝10﹞ 施能泉，「台灣電子大廠跨入醫療器材產業經營策略之研究－以血糖檢測產業為例」，國立清華大學工業與工程管理學系，2011年7月。
﹝11﹞ 楊茹嵐，「台灣醫療器材產業公司組織創新量表建構與實證之研究」，長庚大學企業管理研究所，2008。
﹝12﹞ 陳正倉、林惠玲、陳忠榮、莊春發，「產業經濟學二版」，雙葉書廊有限公司，2007。
﹝13﹞ 陳詩筠，「台灣製藥業結構、行為與績效之影響因素探討」，國立政治大學經濟研究所，2005。
﹝14﹞ 陳瑞煬，「台灣本國銀行業經營績效之分析 ─ 兼論購併之影響」，東吳大學經濟學系，2001。
﹝15﹞ 張淑芳譯，「財務報表這樣看就對了」，臉譜出版社，2004。
﹝16﹞ 張慈映，「醫療器材產業發展現況與趨勢」，工研院產經中心(IEK)，2008/06/04。
﹝17﹞ 經濟部工業局，「2010生技產業白皮書」，2010年7月。
﹝18﹞ 經濟部技術處，2009～2010醫療器材產業年鑑，2009。
﹝19﹞ 經濟部工業局，「2011年生技產業白皮書」，2011年7月。
﹝20﹞ 經濟部投資業務處，「醫療器材產業分析及投資機會」，2008年2月。
﹝21﹞ 齊宇薇，「台灣企業經營績效的影響因素分析：以LED產業為例」，國立中央大學產業經濟研究所碩士在職專班，2010年6月。
﹝22﹞ 劉美君，「市場結構、行為、風險對廠商經營績效之影響-以台灣資訊電子產業之上市公司為例」，中原大學企業管理研究所，2004。
﹝23﹞ 蔡佳佳，「運用SCP 模型分析台灣IC 設計產業」，國立交通大學科技管理研究所，2007。
﹝24﹞ 賴廷松，「研究發展、專利與健保合作對於廠商經營績效的影響─台灣生物科技產業之研究」，國立中央大學產業經濟研究所碩士在職專班，2008。
﹝25﹞ 衛生署，中華民國藥事法，2006。
﹝26﹞ 衛生署，「醫療器材管理辦法」，2006年2月。
二、英文文獻：
〔1〕Bain,J.S., “Barriers to New Competiton：Their Character and consequences in Manufacturing Industry” Cambridge University Press,1956.
〔2〕Demsetz, H., “Industry structure, market rivalry, and public policy”, Journal of Law and Economics, Vol. 16, No. 1, pp. 1-9 ,1973 .
〔3〕Griliches, Z. 1981. Market Value, R&D and Patents. Economic Letters ,7:183-187.
〔4〕Gallet, C. A., “Mergers and market power in the US steel industry”, Applied Economics Letters, Vol. 3, pp. 221-223,1996.
〔5〕Griliches, Z..,” Returns to research and development expenditures in the private sector, in J. Kendrick and B. Vaccara (Eds.). New Developments in Productivity Measurement and Analysis. University of Chicago Press, 419-461,1980.
〔6〕Griliches, Z.. Market Value, R&D and Patents. Economic Letters, 7:183-187,1981.
〔7〕Hrat and Morgan, “Market Structure and Economic Performance in the United Kingdom” Journal of Industrial Economics, p177-193, 1977.
〔8〕Lambson, V.E.,“Is the Concentration-Profit Correlation Partly and Artifact of Lumpy Technology?”, American Economic Review(77), 731-733, 1987 .
〔9〕Mason, E., “Price and production policies of large scale enterprises”, American Economic Review, Vol. 29, No. 1, pp. 61-74 ,1939.
〔10〕Szymanski, D. M., Bharadwaj, S. G., and Varadarajan, P. R., “An analysis of the market share-profitability relationship”, Journal of Marketing, Vol. 57, No. 3, pp. 1-18 ,1993.
〔11〕Shepherd, W. G., “The Elements of Market Structure,” The Review of Economic and Statistics, 54(1): 25-37, 1972.
三、網路資料：
〔1〕公開資訊觀測站：
http://newmops.tse.com.tw/
〔2〕行政院主計
http://www.dgbas.gov.tw/mp.asp?mp=1
〔3〕行政院衛生署網站：
http://140.135.100.101/web/97-project/?q=node/38
〔4〕海關進出口值_統計資料庫查詢系統
http://www.customs.gov.tw/StatisticWeb/IESearch.aspx
〔5〕臺灣博碩士論文加值系統網站：
http://ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi/ccd=Q52tF4/search?mode=basic
|
[Endnote RIS 格式]
[相關文章]
[文章引用]
[完整記錄]
[館藏目錄]
至系統瀏覽論文 ( 永不開放)
plurk
funp
live
udn
HD
myshare
netvibes
friend
youpush
delicious
baidu
Google bookmarks
del.icio.us
hemidemi
facebook
twitter
google
reddit